Readers are advised this story contains graphic images. She was diagnosed with nodular melanoma, an aggressive form of cancer that can grow and spread quickly. "From that day forward, it's been a ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...